533 related articles for article (PubMed ID: 1683709)
41. An investigation of age-related changes in pre- and postjunctional alpha-adrenoceptors in human saphenous vein.
Hyland L; Docherty JR
Eur J Pharmacol; 1985 Aug; 114(3):361-4. PubMed ID: 2998813
[TBL] [Abstract][Full Text] [Related]
42. Alpha adrenoceptor subtypes and receptor reserve in human versus canine saphenous vein: sensitivity to blockade by nitroglycerin.
Eskinder H; Hillard CJ; Olinger GN; Christensen CW; Baker JE; Warltier DC; Gross GJ
J Pharmacol Exp Ther; 1988 Dec; 247(3):941-8. PubMed ID: 2905005
[TBL] [Abstract][Full Text] [Related]
43. Cardiovascular actions of a new selective postjunctional alpha-adrenoceptor antagonist, SK&F 104856, in normotensive and hypertensive dogs.
Hieble JP; Nichols AJ; Fredrickson TA; DePalma PD; Ruffolo RR; Brooks DP
Br J Pharmacol; 1992 Apr; 105(4):992-6. PubMed ID: 1354539
[TBL] [Abstract][Full Text] [Related]
44. Characterization of the alpha 1-adrenoceptor subtype mediating contraction of guinea-pig spleen.
Eltze M
Eur J Pharmacol; 1994 Aug; 260(2-3):211-20. PubMed ID: 7988645
[TBL] [Abstract][Full Text] [Related]
45. Characterization of the postjunctional alpha 2C-adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins.
Görnemann T; von Wenckstern H; Kleuser B; Villalón CM; Centurión D; Jähnichen S; Pertz HH
Br J Pharmacol; 2007 May; 151(2):186-94. PubMed ID: 17375080
[TBL] [Abstract][Full Text] [Related]
46. Are the prejunctional alpha 2-adrenoceptors of the rat vas deferens and submandibular gland of the alpha 2A- or alpha 2D-subtype?
Smith K; Docherty JR
Eur J Pharmacol; 1992 Aug; 219(2):203-10. PubMed ID: 1358640
[TBL] [Abstract][Full Text] [Related]
47. The effect of age on the sensitivity of pre- and postsynaptic alpha-adrenoceptors to agonists and antagonists in the rat.
McAdams RP; Waterfall JF
Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):430-5. PubMed ID: 2881219
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological evidence for heterogeneity of ocular alpha 2 adrenoceptors.
Crosson CE; Heath AR; DeVries GW; Potter DE
Curr Eye Res; 1992 Oct; 11(10):963-70. PubMed ID: 1360396
[TBL] [Abstract][Full Text] [Related]
49. Investigation of neurotransmission in vas deferens from alpha(2A/D)-adrenoceptor knockout mice.
Cleary L; Vandeputte C; Docherty JR
Br J Pharmacol; 2002 Jul; 136(6):857-64. PubMed ID: 12110610
[TBL] [Abstract][Full Text] [Related]
50. Cardiac alpha-adrenoceptors: postjunctional and prejunctional.
Rand MJ; Tung LH; Louis WJ; Story DF
J Mol Cell Cardiol; 1986 Nov; 18 Suppl 5():17-32. PubMed ID: 2433457
[TBL] [Abstract][Full Text] [Related]
51. Pharmacological profile of the novel alpha-adrenoceptor antagonist KT-611 (naftopidil).
Muramatsu I; Yamanaka K; Kigoshi S
Jpn J Pharmacol; 1991 Mar; 55(3):391-8. PubMed ID: 1677438
[TBL] [Abstract][Full Text] [Related]
52. The postjunctional alpha-adrenoceptors of the human saphenous vein.
Steen S; Sjöberg T; Skärby T; Norgren L; Andersson KE
Acta Pharmacol Toxicol (Copenh); 1984 Nov; 55(5):351-7. PubMed ID: 6152103
[TBL] [Abstract][Full Text] [Related]
53. Analysis of agonism at functional prejunctional alpha 2-adrenoceptors of rat vas deferens using operational and null approaches.
Sallés J; Giraldo J; Badia A
Eur J Pharmacol; 1994 Jun; 258(3):229-38. PubMed ID: 7916302
[TBL] [Abstract][Full Text] [Related]
54. Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein.
Flavahan NA; Rimele TJ; Cooke JP; Vanhoutte PM
J Pharmacol Exp Ther; 1984 Sep; 230(3):699-705. PubMed ID: 6088763
[TBL] [Abstract][Full Text] [Related]
55. Evidence for existence of postjunctional alpha 1- and alpha 2-adrenoceptors in cat pulmonary vascular bed.
Hyman AL; Kadowitz PJ
Am J Physiol; 1985 Oct; 249(4 Pt 2):H891-8. PubMed ID: 2864862
[TBL] [Abstract][Full Text] [Related]
56. In vivo analysis of adrenergic and serotoninergic constrictions of the rabbit saphenous vein.
Vayssettes-Courchay C; Ragonnet C; Cordi AA; Verbeuren TJ
Eur J Pharmacol; 2000 Nov; 408(3):277-88. PubMed ID: 11090645
[TBL] [Abstract][Full Text] [Related]
57. Changes in prejunctional potency of B-HT 933 during aging in the rat vas deferens.
Pagenkopf CW; Bourreau JP; Challice CE
Clin Exp Pharmacol Physiol; 1990 Aug; 17(8):557-65. PubMed ID: 2170068
[TBL] [Abstract][Full Text] [Related]
58. Cardiovascular effects of SK&F 104078, a novel alpha-adrenoceptor antagonist, in normotensive and hypertensive rats.
Hieble JP; Sulpizio AC; Gutzait L; Gombar CT
J Cardiovasc Pharmacol; 1990 May; 15(5):845-52. PubMed ID: 1692947
[TBL] [Abstract][Full Text] [Related]
59. Insights into the unusual alpha adrenoceptor subtype in dog saphenous vein using phenoxybenzamine.
Low AM; Lu-Chao H; Loke JC; Kwan CY; Daniel EE
J Pharmacol Exp Ther; 1999 Jan; 288(1):148-56. PubMed ID: 9862765
[TBL] [Abstract][Full Text] [Related]
60. A comparative study of postsynaptic alpha2-adrenoceptors of the dog mesenteric and rat femoral veins.
Paiva MQ; Morato M; Moura D; Guimarães S
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):165-70. PubMed ID: 10494886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
